Sirtuin 1 as a potential molecular target of resveratrol in selected diseases

Hanna Frankenstein1, Jakub Robak1, Urszula Lewandowska2

  • 1Student Wydziału Lekarskiego, Uniwersytet Medyczny w Łodzi.

Postepy Biochemii
|July 16, 2024
PubMed

Insights

Resveratrol, a natural compound, activates sirtuin 1 (a protein linked to aging and disease). This review explores its potential benefits for preventing and treating major human diseases like cancer and diabetes.

Area of Science:

  • Biochemistry and Molecular Biology
  • Gerontology
  • Pharmacology

Background:

  • Sirtuins are crucial proteins involved in aging, cell death, inflammation, and metabolic regulation.
  • Dysregulation of sirtuins contributes to major diseases including cancer, type 2 diabetes, cardiovascular, and neurological disorders.
  • Natural compounds offer potential therapeutic avenues with fewer side effects than conventional treatments.

Purpose of the Study:

  • To review the potential benefits of resveratrol as a sirtuin 1 activator.
  • To explore resveratrol's role in disease prevention and treatment.
  • To summarize current research on resveratrol and sirtuin 1 interactions.

Main Methods:

  • Literature review of existing studies on resveratrol and sirtuin 1.
  • Analysis of research investigating resveratrol's effects on aging and disease processes.
  • Synthesis of data on the therapeutic potential of resveratrol.

Main Results:

  • Resveratrol is a potent natural activator of sirtuin 1.
  • Sirtuin 1 modulation by resveratrol shows promise in slowing aging and cell death.
  • Resveratrol demonstrates anti-inflammatory and metabolic regulatory effects relevant to disease management.

Conclusions:

  • Resveratrol's activation of sirtuin 1 suggests significant therapeutic potential.
  • Natural compounds like resveratrol may offer alternative strategies for managing chronic diseases.
  • Further research is warranted to fully elucidate resveratrol's clinical applications.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K